Finance

Lists
GOVX:NASDAQ
Geovax Labs Inc
US$ ०.२९
+०.२१%
(+०.०००६०) 1D
अक्टोबर ८, १३:३१:०८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GOVX...
Open
US$ ०.३०
High
US$ ०.३१
Low
US$ ०.२८
Mkt. cap
२६.२४ लाख
Avg. vol.
८.७० लाख
Volume
२.१८ लाख
52-wk high
US$ १५.७५
52-wk low
US$ ०.२८
EPS
-US$ १३.९२
Beta
३.६९
Shares outstanding
१.०१ करोड
No. of employees
१९
Open
US$ ०.३०
High
US$ ०.३१
Low
US$ ०.२८
Mkt. cap
२६.२४ लाख
Avg. vol.
८.७० लाख
Volume
२.१८ लाख
52-wk high
US$ १५.७५
52-wk low
US$ ०.२८
EPS
-US$ १३.९२
Beta
३.६९
Shares outstanding
१.०१ करोड
No. of employees
१९
News stories
From web sources and news partners
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees१९
Founded१९८८
Headquartersएट्लान्टा, जर्जिया, संयुक्त राज्य अमेरिका
Sector-
Websitegeovax.com
Analyst ratings
Based on 1 analyst giving stock ratings to GOVX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GOVX in the last 3 months
Highest
Current US$ ०.२९
US$ १०.०० (+३,३४८.२८%)
Average
US$ १०.०० (+३,३४८.२८%)
Lowest
US$ १०.०० (+३,३४८.२८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
US$ १०.००
+३,३४८.३%
09/17/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
US$ १०.००
+३,३४८.३%
05/26/2026
Jason Kolbert
D. Boral Capital
Hold
Downgraded
-
-
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
५०.४४ लाख
२९.९४ लाख
३९.०३ लाख
३१.११ लाख
Cost of revenue
५०.४४ लाख
२९.९४ लाख
३९.०३ लाख
३१.११ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१३.३० लाख
१४.४७ लाख
१३.६९ लाख
१३.३२ लाख
Operating expense
१३.३० लाख
१४.४७ लाख
१३.६९ लाख
१३.३२ लाख
Total operating expenses
६३.७३ लाख
४४.४२ लाख
५२.७३ लाख
४४.४२ लाख
Operating income
-६३.७३ लाख
-४४.४२ लाख
-५२.७३ लाख
-४४.४२ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-६३.१९ लाख
-४४.१८ लाख
-५२.६२ लाख
-४४.२७ लाख
EBT excluding unusual items
-६३.१९ लाख
-४४.१८ लाख
-५२.६२ लाख
-४४.२७ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-६३.१९ लाख
-४४.१८ लाख
-५२.६२ लाख
-४४.२७ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
५४.३० हजार
२३.३३ हजार
१०.९६ हजार
१५.४९ हजार
Interest expense
-
-
-
-
Net interest expenses
५४.३० हजार
२३.३३ हजार
१०.९६ हजार
१५.४९ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-६३.५६ लाख
-४४.२४ लाख
-५२.६१ लाख
-४४.३० लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू